Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Interleukin-1 (IL-1) secretion pathway refers to the processes by which IL-1 family cytokines, particularly IL-1β and IL-1α, are produced, matured, and secreted from cells. These cytokines are central mediators of inflammation and immune responses. Unlike most secreted proteins, IL-1β lacks a classical signal peptide and is not exported via the conventional endoplasmic reticulum (ER)-Golgi route. The pathway relies on inflammasome-driven maturation followed by non-classical export involving gasdermin D pores rather than ER-Golgi trafficking. Its activity underpins both protective host responses and pathological inflammation depending on context.
Blockade of IL-1 signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 1 Secretion Pathway (IL-1 Secretion Pathway).